MedTrace Logo

Cognitive, Emotional, Physical and Psychosocial Effects of Panax Quinquefolius L

NCT00527969 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2008-03-12

No results posted yet for this study

Summary

The purpose of this study is to determine the efficacy and safety of REMEMBER-fX (HT1001, an extract of Panax quinquefolius) in a human sample using standard clinical neuropsychological instruments and side effects rating scales.

Conditions

  • Memory
  • Learning
  • Attention
  • Cognition
  • Well-Being

Interventions

DRUG

HT1001 extract of Panax quinquefolius L

Sponsors & Collaborators

  • CV Technologies

    lead INDUSTRY

Principal Investigators

  • Scot E Purdon, PhD · Department of Psychiatry, University of Alberta

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
35 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-07-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00527969 on ClinicalTrials.gov